Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (unaudited)

v2.4.0.6
Consolidated Statements of Operations (unaudited) (USD $)
 3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Consolidated Statements of Operations [Abstract]    
Revenues $ 1,653,430 $ 1,121,561
Cost of goods sold 439,158 338,777
Gross profit 1,214,272 782,784
Costs and expenses:    
Sales and marketing 1,628,608 856,976
Research and development 296,131 105,591
General and administrative 1,230,608 722,165
Total costs and expenses 3,155,347 1,684,732
Loss from operations (1,941,075) (901,948)
Other income (expense):    
Interest expense (125,125) (202,799)
Interest expense - deferred financing costs (34,951) (1,059,167)
Change in fair value of warrant liability   (119,460)
Other income (expense) (8,174) (7,900)
Total other income (expense) (168,250) (1,389,326)
Net loss (2,109,325) (2,291,274)
Preferred Stock dividends (assumes all paid)   375,779
Net loss available to common shareholders $ (2,109,325) $ (2,667,053)
Weighted Average Common Shares outstanding--basic and diluted 11,062,339 1,205,600
Loss Per Common share--basic and diluted $ (0.19) $ (2.21)